Opening & Welcome

Casey Orvin, President, SCRS (USA)
Vivienne van de Walle, MD, PhD, CPI, Director & Owner, PT&R (The Netherlands)

The Site Landscape: Benchmark Your Site

Vivienne van de Walle, MD, PhD, CPI, Director & Owner, PT&R (The Netherlands)
Nikki Dewick, BSc (Hons), Process & Standards Lead, Pfizer (UK)
Matyas Faluvegi, MD, Country Head SMM, Nordics, AstraZeneca (Hungary)
Agnieszka Gackowska MD, Sr. Director, Clinical Feasibility & Site Alliance, Global, PAREXEL (Poland)
Martin Gibson, MD, PhD, FRCP, CEO, NorthWest EHealth (UK)
Stephen Jasperse, BSc (Hons), Sr. Director, Site Partnerships, Covance (UK)
Hayley Jewell, PhD, Site Engagement Director EMEA, Lilly (UK)
Karen McIntyre, MSc, Sr. Director, Global Lead Catalyst Program, Syneos Health (UK)
Christine Phillips, CSci, MSc, PhD, FRSB, Sr. Director, Head of Site ID EMEA, IQVIA (UK)
Helena Sigal, MD, Managing Director, Sigal SMS (Germany)
Lilette Riva, Global SIte Partnership Manager, Sanofi (Italy)

Creating Strategic Initiatives and Partnerships to Drive Patient-centered Trials

Amanda Rangel, MS, CCRC, VP of Business Development, VirTrial (USA)
Piotr Sawicki, MS, Head of Patient Engagement, CEE Region, Synexus (Poland)
Clare Grace, PhD, VP, Site & Patient Services, Syneos Health (UK)
Rachael Buck, PhD, Sr. Director of Programme Management, MeDiNova (UK)
Diana Foster, PhD, VP, Strategy & Special Projects, SCRS (USA)

SPRIA Europe: Welkom

SPRIA Europe: SCALA Clinical Research

SPRIA Europe: Slovak Research Center

Breakout Session I: The GDRP: A Year Gone By

Eric Klaver, GCP Auditor/CR Trainer, FourPlus Clinical (The Netherlands)
Vivienne van de Walle, MD, PhD, CPI, Director & Owner, PT&R (The Netherlands)

Breakout Session II: Impact of Brexit and the EMA Moving to the Mainland

Fiona Maini, BSc, MSc, Principal, Global Compliance and Strategy, Medidata Solutions (UK)
Borislav Borissov, MD, PhD, DSc, Country Manager, Synexus (Bulgaria)
Parastoo Karoon, PhD, Principal Consultant, PAREXEL (UK)

Breakout Session III: Soft Skills Create Strong Sites

Jonathon Crowther, PhD, Site Intelligence Lead, Pfizer (Belgium)
Ksenia Teplova-Bareysha, MD, MBA, Country Head, Site Management, Bayer (Russian Federation)
Sergii Myronenko, MD, CEO, PharmaSich CRO (Ukraine)
Jiri Paseka, MD, Chief Medical Officer, GCP-Service International (Czech Republic)

SCRS Initiatives Update

Dan Milam, VP Global Engagement, SCRS (USA)
Diana Foster, PhD, VP Strategy & Special Projects, SCRS (USA)

Rise of the Intelligent Medical IoT

Mark Wolff, PhD, Advisory Industry Consultant, Chief Health Analytics Strategist, Global IoT Division, SAS Institute (USA)

How TranCelerate Collaborates to Solve Industry Challenges

Brian Egan, MA, Global Engagement Manager, TransCelerate BioPharma (USA)
Diane Driver, Head Program Delivery, Development & Medical (Patient Value) Practices, UCB (UK)
Sylvia Eberhardt, Shared Investigator Platform and Investigator Registry Lead, Roche (Switzerland)
Denise Reyes, Portfolio Director, TransCelerate BioPharma (USA)

Evidence-based Tactics & Tools Driving Site Selection

Oriol Serra Ortiz, MS, MBA, Global Head Site Intelligence & Selection, Pfizer (USA)
Sylvia Eberhardt, Shared Investigator Platform and Investigator Registry Lead, Roche (Switzerland)

Virtual Trials: Emerging Technologies That Are Transforming the Clinical Research Landscape

Fiona Maini, BSc, MSc, Principal Global Strategy and Compliance, Medidata Solutions (UK)
Ben Quartley, PhD, Head of Feasibility, Patient Recruitment & Engagement, Covance (UK)
Robin Douglas, MA, CCRC, Sr. Director, Head of Site Operations, Virtual Trials, IQVIA (USA)
Jackie Kent, Sr. VP, Head of Product, Medidata Solutions (USA)

Closing Remarks

Casey Orvin, President, SCRS (USA)
Vivienne van de Walle, MD, PhD, CPI, Director & Owner, PT&R (The Netherlands)